Scinai Immunotherapeutics Ltd. (TLV:BVXV)
Israel
· Delayed Price · Currency is ILS · Price in ILA 49.30
-1.00 (-1.99%)
At close: Jan 18, 2018
Scinai Immunotherapeutics Revenue
In the year 2025, Scinai Immunotherapeutics had annual revenue of $1.31M USD with 99.24% growth. Scinai Immunotherapeutics had revenue of $269.00K in the quarter ending December 31, 2025, with 30.58% growth.
Revenue
$1.31M
Revenue Growth
+99.24%
P/S Ratio
1.43
Revenue / Employee
$42.29K
Employees
31
Market Cap
5.99M ILS
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Smart Agro - | -6.18M |
| Shure-Tech Investments - Limited Partnership | -21.55M |
| Storage Drop Storage Technologies | 19.00K |
| Petrotx - Limited Partnership | 17.53M |
| Imed Infinity Medical-Limited Partnership | 720.49K |
| Menara Ventures Xl - Limited Partnership | 941.00K |
Scinai Immunotherapeutics News
- 5 days ago - Why Scinai Immunotherapeutics Stock Is Skyrocketing 90% Higher Today - Benzinga
- 5 days ago - Scinai Immunotherapeutics Announces $2.61 Million Private Placement Financing - PRNewsWire
- 23 days ago - Scinai Completes Strategic Reorganization to Establish Dedicated CDMO Platform and Lean R&D Structure; Outlines 2026 Priorities - PRNewsWire
- 4 weeks ago - Scinai Reports Full-Year 2025 Results, with CDMO Revenues Doubling and Strategic Expansion Through Recipharm Collaboration - PRNewsWire
- 5 weeks ago - Scinai Immunotherapeutics Highlights Expanded CDMO Platform and Immunology Pipeline at BIO-Europe Spring® 2026 - PRNewsWire
- 6 weeks ago - Scinai Immunotherapeutics Receives Nasdaq Notification Regarding Minimum Bid Price - PRNewsWire
- 2 months ago - Scinai Signs Second Amendment to PinCell Option Agreement and Submits Revised €12 Million Non-Dilutive FENG Application to Advance PC111 Through Human Proof of Concept - PRNewsWire
- 2 months ago - Scinai Announces Expanded Israel Innovation Authority Support for Robotic Aseptic Fill & Finish Platform - PRNewsWire